Clinical Manifestations

Area of Science:

• Neurology
• Gerontology
• Cognitive Science

Background:

• Mild Cognitive Impairment (MCI) affects over 12 million US individuals, with a high risk of progressing to dementia.
• Current screening methods for MCI are challenging, leading to underdiagnosis in 90% of cases.
• The development of disease-modifying therapies necessitates improved tools for early and accurate MCI detection.

Purpose of the Study:

• To develop a novel, data-driven tool for rapid and accurate cognitive assessment.
• To identify and optimize a brief cognitive test for detecting Mild Cognitive Impairment (MCI).
• To compare the efficacy of the new tool against existing cognitive assessments and clinical diagnoses.

Main Methods:

• Analysis of over 10,000 individuals' data from the National Alzheimer's Coordinating Center (NACC) Uniform Data Set version 3 (UDSv3).
• Data-driven selection and weighting of information-efficient test items.
• Assessment of diagnostic accuracy using receiver operating characteristic (ROC) area under the curve (AUC) values.

Main Results:

• A 4-item Brief Optimized Cognitive Composite (BOCC) test was developed, with a 4-5 minute administration time.
• The BOCC demonstrated significantly higher AUC values than the MoCA in detecting MCI (0.87 vs 0.80) and mild dementia (0.99 vs 0.95).
• The BOCC score showed superior predictive power for 6-year dementia conversion compared to clinical diagnoses (AUCs: 0.95 vs 0.88).

Conclusions:

• A brief, 4-5 minute cognitive test (BOCC) can significantly outperform the MoCA in detecting MCI.
• The BOCC accurately predicts future dementia decline, comparable to or exceeding clinical diagnoses.
• This tool has the potential to improve MCI detection rates in the large elderly population.